Companies › RNXT
RENOVORX INC (RNXT)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001574094 · EDGAR filings · Updated 2026-07-02
RENOVORX INC (RNXT) has reported institutional ownership of 19.0%, with 31 institutional managers holding positions valued at $8.58M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-02 — Current report (8-K) filed
- 2026-06-30 — Employee-plan registration (S-8) filed
- 2026-06-30 — Current report (8-K) filed
- 2026-06-24 — Insider transaction reported (Form 4)
- 2026-05-21 — Insider transaction reported (Form 4)
- 2026-05-15 — 10-K/A filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, RENOVORX INC has 31 institutional holders and institutional ownership of 19.0%.
Insider activity
Insiders reported 29 transactions (26 buys, 0 sells) across 5 reporting insiders, with a net reported value of $222.8K.
Data flags from SEC filings
Related companies
MYOMO INC (MYO) · Curis Inc (CRIS) · TVARDI THERAPEUTICS INC COM (TVRD) · Bausch Lomb Corp (BLCO) · SS INNOVATIONS INTERNATIONAL COM NEW (SSII) · VISTAGEN THERAPEUTICS INC (VTGN)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.